enGene
Presence
enGene is a company listed under the stock ticker ENGN (CA).
Acquisition, funding and merger involving enGene.
- enGene is now listed under the stock ticker ENGN. (posted on November 3 2023).
Executives
View the org chart displaying its 12 main executives
Most searched biographies at enGene
Popular executive movements at enGene
- Raj Pruthi has joined the company as Senior Vice President, Urologic Oncology and Clinical Development (posted on April 12 2024).
- Jason Hanson, who is Chief Executive Officer will soon leave the company (posted on February 15 2024).
- Lee Giguere has joined the company as Chief Legal Officer and Corporate Secretary (posted on January 31 2024).
Click here to view some more movements at enGene
Create your alert
to follow the executive moves at enGene.
Biotechnology
enGene has 2,290 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
- Karius has just announced a $100 Million fundraising (posted on May 3 2024).
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by enGene
- enGene Holdings Inc. News powered by B2i Technologies - SmartWireenGene Holdings Inc. News powered by B2i Technologies - SmartWire
- enGene - Communiqués de presse
- enGene - Press Releases
Social media about enGene
- enGene on Wikipedia, Google News & Yahoo Finance
- enGene on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Jason Hanson 
